Commodities
China Pharma Stock Crashes 70%: What a $5M Direct Offering Signals for Small-Cap Biotech Traders
A Chinese pharmaceutical company's stock cratered nearly 70% after announcing a $5 million direct offering, triggering classic dilution-driven selling. The move highlights the brutal mechanics of small-cap biotech capital raises and the risks embedded in thinly traded Chinese equities listed on US exchanges.